GSK says USFDA wants more information on pulmonary drug Medical Dialogues Bureau8 Sept 2018 9:45 AM ISTLONDON: GlaxoSmithKline (GSK) said that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic...
French drugmakers urge Brexit negotiators to safeguard supply chain Medical Dialogues Bureau8 Sept 2018 9:30 AM ISTFrench drugmakers are urging European and British negotiators ahead of a crunch Brexit meeting next month to ensure the free circulation of medicines...
Renaming drug regulator CDSCO: Health ministry invites suggestions Ruby Khatun Khatun7 Sept 2018 1:28 PM ISTThe Drugs Technical Advisory Board (DTAB) in its 75th meeting held on January 3, 2017, had recommended renaming CDSCO as Indian Drugs Administration,...
Aurobindo to acquire Sandoz US dermatology, oral solids business for about Rs 6,470 crore CASH Ruby Khatun Khatun7 Sept 2018 12:44 PM ISTOverall the transaction will position Aurobindo as the 2nd largest dermatology player and the 2nd largest generics company in the US by prescriptions,...
Lupin to train over 1,000 graduates for pharma industry Medical Dialogues Bureau7 Sept 2018 10:15 AM ISTNew Delhi: Pharmaceutical giant, Lupin Limited expects to train more than 1,000 undergraduates into pharma professionals by the year 2020 under its...
FDA extends review of Roche's Tecentriq by three months Medical Dialogues Bureau7 Sept 2018 10:00 AM ISTZURICH: Roche said the U.S. Food and Drug Administration (FDA) had extended by three months the review period for Tecentriq in combination therapy as...
Insurance tactic drags down US drug prices in second quarter: analyst Ruby Khatun Khatun7 Sept 2018 9:45 AM ISTNEW YORK: U.S. drug prices fell again in the second quarter, likely due to new tactic insurers are using to limit financial assistance drugmakers...
Sanofi to pay more than 25 million dollar to resolve corruption charges: SEC Ruby Khatun Khatun7 Sept 2018 9:30 AM ISTWASHINGTON: French pharmaceutical giant Sanofi will pay more than $25 million to settle charges that its Kazakhstan and the Middle East subsidiaries...
Ranbaxy Fiasco: Malvinder Singh told to pay 3.5 million Singapore dollars Ruby Khatun Khatun6 Sept 2018 1:19 PM ISTNew Delhi: The Delhi High Court on Wednesday directed former Ranbaxy Laboratories Ltd promoter Malvinder Singh to deposit with it 3.5 million...
Zydus Cadila gets USFDA approval for antiviral drug Ruby Khatun Khatun6 Sept 2018 10:44 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Acyclovir injection, used to treat...
ProQR drug for rare childhood blindness succeeds in early trial Ruby Khatun Khatun6 Sept 2018 9:45 AM ISTDutch drug developer ProQR Therapeutics NV said its interim analysis showed that an early-stage trial of an experimental treatment for a rare form of...
UK deal makes Novartis cancer cell therapy available to kids Ruby Khatun Khatun6 Sept 2018 9:30 AM ISTLONDON: Health authorities in England have agreed with Swiss drugmaker Novartis to fast-track access to its expensive CAR-T cell therapy Kymriah and...
